STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic CancerSummary
Background & Aims: Pancreatic ductal adenocarcinoma (PDA) is a lethal chemoresistant cancer that exhibits early metastatic spread. The highly immunosuppressive PDA tumor microenvironment renders patients resistant to emerging immune-targeted therapies. Building from our prior work, we evalua...
Main Authors: | Emily P. Vonderhaar, Nicholas S. Barnekow, Donna McAllister, Laura McOlash, Mahmoud Abu Eid, Matthew J. Riese, Vera L. Tarakanova, Bryon D. Johnson, Michael B. Dwinell |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Cellular and Molecular Gastroenterology and Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352345X21000242 |
Similar Items
-
Salmonella as an Innovative Therapeutic Antitumor Agent
by: Wen-Wei Chang, et al.
Published: (2014-08-01) -
IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections
by: Kelly M. Shepardson, et al.
Published: (2018-11-01) -
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
by: Alireza Labani-Motlagh, et al.
Published: (2020-05-01) -
STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
by: Donna McAllister, et al.
Published: (2019-03-01) -
Improvement of Antitumor Therapies Based on Vaccines and Immune-Checkpoint Inhibitors by Counteracting Tumor-Immunostimulation
by: Paula Chiarella, et al.
Published: (2018-01-01)